L3VLUP
ProSign in

VCEL · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

VCELAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • VCEL
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterVCELAMGN
Q3 20202 holders, $6.8m16 holders, $16.3bn
Q4 20203 holders, $19m19 holders, $14.0bn
Q1 20216 holders, $68m16 holders, $14.5bn
Q2 20213 holders, $37m23 holders, $13.8bn
Q3 20212 holders, $5.0m24 holders, $11.6bn
Q4 20211 holders, $2.1m21 holders, $10.4bn
Q1 2022none listed holders, n.a.23 holders, $9.9bn
Q2 20221 holders, $1.3m28 holders, $9.7bn
Q3 2022none listed holders, n.a.21 holders, $7.9bn
Q4 2022none listed holders, n.a.24 holders, $9.3bn
Q1 20231 holders, $27m22 holders, $8.4bn
Q2 20231 holders, $19m26 holders, $7.4bn
Q3 20232 holders, $21m26 holders, $8.7bn
Q4 20231 holders, $479k24 holders, $8.4bn
Q1 20242 holders, $1.6m25 holders, $6.7bn
Q2 20241 holders, $1.0m20 holders, $8.0bn
Q3 20241 holders, $1.0m21 holders, $8.8bn
Q4 20242 holders, $2.7m20 holders, $8.2bn
Q1 20253 holders, $32m25 holders, $12.0bn
Q2 20252 holders, $40m20 holders, $10.2bn
Q3 20254 holders, $37m17 holders, $10.4bn
Q4 20253 holders, $11m19 holders, $18.0bn
Q1 20261 holders, $1.3m15 holders, $21.4bn
Q2 20262 holders, $14m23 holders, $24.9bn
VCEL

Vericel Corp

Holders
1
Reported value
$1.3m
Buyers
18
Sellers
13

Breadth +5 among 91 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
15
Reported value
$21.4bn
Buyers
17
Sellers
15

Breadth +2 among 91 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q1 2026

Among the 16 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only VCEL (1)

Winton Group Ltd

Only AMGN (15)

AllianceBernstein LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Dodge & Cox, Fidelity (FMR LLC), Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Neuberger Berman Group LLC, Quantbot Technologies LP, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →